This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 913542-71-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
913542-71-9 / 2-[7-(carboxymethyl)-4,10-bis[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
Standard CAS: 913542-71-9
Multi CAS: No
Basic Information
copy
CAS
913542-71-9 copy
Multi CAS
No copy
Molecular Formula
C24H44N4O8 copy
Molecular Weight
516.600000 copy
Exact Mass
516.315914 copy
InChI
InChI=1S/C24H44N4O8/c1-23(2,3)35-21(33)17-27-11-7-25(15-19(29)30)9-13-28(18-22(34)36-24(4,5)6)14-10-26(8-12-27)16-20(31)32/h7-18H2,1-6H3,(H,29,30)(H,31,32) copy
InChIKey
WRUJMBQKNNMUAY-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
36 copy
Fraction Csp3
0.83 copy
Rotatable bonds
8 copy
H-bond acceptors
10 copy
H-bond donors
2 copy
Molar refractivity
132.72 copy
TPSA
140.16 copy
LogP / Solubility
WLOGP
0.06 copy
MLOGP
0.09 copy
XLogP3
-3.4 copy
Consensus LogP
-1.08 copy
Log S (ESOL)
-2.55 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-3.84 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-4.03 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-5.83 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
No copy
Egan
No copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
5.5 copy